Literature DB >> 31219033

The Postopera tive Quality of Life in Children and Adolescents with Craniopharyngioma.

Maria Eveslage1, Gabriele Calaminus, Monika Warmuth-Metz, Rolf-Dieter Kortmann, Fabian Pohl, Beate Timmermann, Martin Ulrich Schuhmann, Jörg Flitsch, Andreas Faldum, Hermann Lothar Müller.   

Abstract

BACKGROUND: Craniopharyngioma is a tumor of low histological malignancy resulting from an anomaly of embryonic development. Affected children and adolescents are being studied with respect to their quality of life, progression-free survival, and overall survival in the framework of the ongoing KRANIOPHARYNGEOM 2007 project.
METHODS: This prospective, multicenter project consists of a randomized trial with an adaptive design combined with a purely observational study. The randomized, unblinded trial includes patients whose tumors have been incompletely resected and is intended to compare the outcomes of immediate postoperative radiotherapy versus radiotherapy on progression. Its primary endpoint is quality of life as assessed subjectively by the patients them- selves with the "Pediatric Quality of Life" questionnaire (PEDQOL). In exploratory analyses, linear mixed models were used to study the effect of further factors on quality of life.
RESULTS: An interim intention-to-treat analysis of the randomized trial revealed only minor differences between the treatment arms with respect to quality of life (n = 24). The exploratory analyses (n = 131) showed that preoperative involvement of, or operative damage to, the anterior and posterior regions of the hypothalamus was associated with a lower quality of life. Complete resection was followed by a lower quality of life than incomplete resection. Radiotherapy, a common treatment for tumors that progress after incomplete resection, was also associated with a lower quality of life.
CONCLUSION: Hypothalamus-sparing treatment approaches are recommended to optimize the quality of life of children and adolescents with cranio- pharyngioma. The available evidence does not support any recommendation as to when radiotherapy should be performed after incomplete resection so that the best quality of life can be achieved.

Entities:  

Year:  2019        PMID: 31219033      PMCID: PMC6620763          DOI: 10.3238/arztebl.2019.0321

Source DB:  PubMed          Journal:  Dtsch Arztebl Int        ISSN: 1866-0452            Impact factor:   5.594


  30 in total

1.  More or less? Treatment strategies in childhood craniopharyngioma.

Authors:  Hermann L Müller
Journal:  Childs Nerv Syst       Date:  2006-02       Impact factor: 1.475

2.  Strategies for including patients recruited during interim analysis of clinical trials.

Authors:  Andreas Faldum; Gerhard Hommel
Journal:  J Biopharm Stat       Date:  2007       Impact factor: 1.051

Review 3.  Craniopharyngioma: modern concepts in pathogenesis and treatment.

Authors:  Maria Luisa Garrè; Armando Cama
Journal:  Curr Opin Pediatr       Date:  2007-08       Impact factor: 2.856

4.  Quality of life in children and adolescents with cancer. First results of an evaluation of 49 patients with the PEDQOL questionnaire.

Authors:  G Calaminus; S Weinspach; C Teske; U Göbel
Journal:  Klin Padiatr       Date:  2000 Jul-Aug       Impact factor: 1.349

5.  Obesity after childhood craniopharyngioma--German multicenter study on pre-operative risk factors and quality of life.

Authors:  H L Müller; K Bueb; U Bartels; C Roth; K Harz; N Graf; R Korinthenberg; M Bettendorf; J Kühl; P Gutjahr; N Sörensen; G Calaminus
Journal:  Klin Padiatr       Date:  2001 Jul-Aug       Impact factor: 1.349

Review 6.  Pediatric craniopharyngiomas: classification and treatment according to the degree of hypothalamic involvement.

Authors:  Stéphanie Puget; Matthew Garnett; Alison Wray; Jacques Grill; Jean-Louis Habrand; Nathalie Bodaert; Michel Zerah; Mercia Bezerra; Dominique Renier; Alain Pierre-Kahn; Christian Sainte-Rose
Journal:  J Neurosurg       Date:  2007-01       Impact factor: 5.115

7.  Longitudinal study on quality of life in 102 survivors of childhood craniopharyngioma.

Authors:  Hermann L Müller; Gina Bruhnken; Angela Emser; Andreas Faldum; Nicole Etavard-Gorris; Ursel Gebhardt; Reinhard Kolb; Niels Sörensen
Journal:  Childs Nerv Syst       Date:  2005-06-18       Impact factor: 1.475

Review 8.  Craniopharyngioma: the pendulum of surgical management.

Authors:  Christian Sainte-Rose; Stéphanie Puget; Alison Wray; Michel Zerah; Jacques Grill; Raja Brauner; Nathalie Boddaert; Alain Pierre-Kahn
Journal:  Childs Nerv Syst       Date:  2005-08-03       Impact factor: 1.475

9.  Body Mass Index variations: centiles from birth to 87 years.

Authors:  M F Rolland-Cachera; T J Cole; M Sempé; J Tichet; C Rossignol; A Charraud
Journal:  Eur J Clin Nutr       Date:  1991-01       Impact factor: 4.016

10.  Surgery with or without radiation therapy in the management of craniopharyngiomas in children and young adults.

Authors:  Diana C H Stripp; Amit Maity; Anna J Janss; Jean B Belasco; Zelig A Tochner; Joel W Goldwein; Thomas Moshang; Lucy B Rorke; Peter C Phillips; Leslie N Sutton; Hui-Kuo G Shu
Journal:  Int J Radiat Oncol Biol Phys       Date:  2004-03-01       Impact factor: 7.038

View more
  10 in total

1.  Craniopharyngioma: The Benefits of a Conservative Approach.

Authors:  Hans Clusmann; Anke Höllig
Journal:  Dtsch Arztebl Int       Date:  2019-05-03       Impact factor: 5.594

2.  Craniopharyngiomas presenting as incidentalomas: results of KRANIOPHARYNGEOM 2007.

Authors:  Svenja Boekhoff; Brigitte Bison; Maria Eveslage; Panjarat Sowithayasakul; Hermann L Müller
Journal:  Pituitary       Date:  2019-10       Impact factor: 4.107

3.  Reply to: Understanding treatment options in craniopharyngioma better.

Authors:  Hermann L Müller
Journal:  Nat Rev Dis Primers       Date:  2020-04-16       Impact factor: 52.329

Review 4.  Hypothalamic syndrome.

Authors:  Hermann L Müller; Maithé Tauber; Elizabeth A Lawson; Jale Özyurt; Brigitte Bison; Juan-Pedro Martinez-Barbera; Stephanie Puget; Thomas E Merchant; Hanneke M van Santen
Journal:  Nat Rev Dis Primers       Date:  2022-04-21       Impact factor: 52.329

5.  Upfront adjuvant irradiation versus postoperative surveillance following incomplete surgical resection of craniopharyngiomas in children and young adults.

Authors:  Sauradeep Sarkar; Sophy Korula; Sarah Mathai; Anna Simon; Rajesh Balakrishnan; Selvamani Backianathan; Ari G Chacko
Journal:  Childs Nerv Syst       Date:  2022-08-09       Impact factor: 1.532

6.  Growth hormone ameliorates hepatopulmonary syndrome and nonalcoholic steatohepatitis secondary to hypopituitarism in a child: A case report.

Authors:  Xiao-Yuan Zhang; Ke Yuan; Yan-Lan Fang; Chun-Lin Wang
Journal:  World J Clin Cases       Date:  2022-06-26       Impact factor: 1.534

Review 7.  Can We Compare the Health-Related Quality of Life of Childhood Cancer Survivors Following Photon and Proton Radiation Therapy? A Systematic Review.

Authors:  Mikaela Doig; Eva Bezak; Nayana Parange; Peter Gorayski; Victoria Bedford; Michala Short
Journal:  Cancers (Basel)       Date:  2022-08-15       Impact factor: 6.575

Review 8.  Current Advances in the Management of Adult Craniopharyngiomas.

Authors:  Montserrat Lara-Velazquez; Yusuf Mehkri; Eric Panther; Jairo Hernandez; Dinesh Rao; Peter Fiester; Raafat Makary; Michael Rutenberg; Daryoush Tavanaiepour; Gazanfar Rahmathulla
Journal:  Curr Oncol       Date:  2022-03-04       Impact factor: 3.677

9.  Cerebral Infarction in Childhood-Onset Craniopharyngioma Patients: Results of KRANIOPHARYNGEOM 2007.

Authors:  Svenja Boekhoff; Brigitte Bison; Daniela Genzel; Maria Eveslage; Anna Otte; Carsten Friedrich; Jörg Flitsch; Hermann L Müller
Journal:  Front Oncol       Date:  2021-07-14       Impact factor: 6.244

10.  Stereotactic cysto-ventricular catheters in craniopharyngiomas: an effective minimally invasive method to improve visual impairment and achieve long-term cyst volume reduction.

Authors:  Christine Steiert; Juergen Grauvogel; Roland Roelz; Theo Demerath; Daniel Schnell; Juergen Beck; Volker Arnd Coenen; Peter Christoph Reinacher
Journal:  Neurosurg Rev       Date:  2021-03-05       Impact factor: 3.042

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.